Where does testosterone sit in UK drug law?
Testosterone and its esters are anabolic and androgenic steroids, controlled as Class C drugs under the Misuse of Drugs Act 1971 and listed in Schedule 4 Part II of the Misuse of Drugs Regulations 2001. Both halves of that placement do work. The Class C classification sets the criminal penalties: unauthorised supply or production carries up to fourteen years' imprisonment and an unlimited fine on indictment, which is the number that separates the regulated sector described in our TRT market analysis from the gym-bag economy it competes with. The Schedule 4 Part II placement sets the day-to-day handling rules, and they are markedly lighter than the Schedule 2 regimes this site has covered for cannabis-based products and ADHD stimulants, which is exactly why operators moving between verticals get the details wrong in both directions.
Two features of the Part II list matter to TRT operators specifically. First, it is a list of substances, not products: every testosterone preparation, gel, injection or compounded cream, carries the same controlled drug status regardless of licensing. Second, the list is wider than testosterone. It includes the other anabolic and androgenic steroids, clenbuterol, and the growth hormones including somatropin, and it includes chorionic gonadotrophin (hCG), which many TRT services prescribe adjunctively. A clinic that thinks of itself as prescribing one controlled drug is frequently prescribing two, and its pharmacy's records should reflect that. Part II also differs from Part I of the same Schedule, the benzodiazepine-type list, in the possession exemption covered below, so read anything written about "Schedule 4" generally with the Part distinction in mind.
What does Schedule 4 spare you, and what remains?
It spares the pharmacy the heaviest infrastructure of controlled drug practice and leaves the discipline that actually protects patients. The comparison with the Schedule 2 verticals, side by side:
| Requirement | Schedule 2 (CBPMs, ADHD stimulants) | Schedule 4 Part II (testosterone, hCG) |
|---|---|---|
| CD register | Every receipt and supply, running balances, two-year retention | Not required |
| Safe custody | Approved CD cabinet or safe | Not required; store responsibly as any POM |
| Private prescription form | FP10PCD with the prescriber's six-digit private CD identifier | Ordinary private prescription; no designated form, no identifier |
| NHSBSA submission | Dispensed forms submitted monthly | Not required |
| Prescription validity | 28 days from the appropriate date | 28 days from the appropriate date to the first dispensing |
| Repeats | Not permitted | Permitted where the prescriber directs |
| Emergency supply | None (phenobarbital excepted) | Permitted, maximum five days' treatment |
| Quantity good practice | 30 days' supply | 30 days' supply |
| Witnessed destruction | Authorised witness for stock destruction | Not required; dispose via the proper waste route |
| Supply offence | Class B or C penalties by drug | Class C: up to fourteen years for unauthorised supply |
The pattern is the one our TRT PMR guide draws for systems: the compliance centre of gravity moves from CD paperwork to clinical records. Schedule 4 removes the register; it does not remove the need to evidence that a controlled drug reached the right patient against a verified prescription with the monitoring the framework in our remote prescribing standards guide expects, because testosterone sits squarely in that guidance's high-risk categories as a controlled drug requiring ongoing monitoring.
"Schedule 4 spares the pharmacy the register; it spares nobody the supply offence."
What are the prescription rules, and how do private scripts work?
A testosterone prescription follows the Schedule 4 pattern: it is valid for 28 days from the appropriate date, meaning the first dispensing must occur inside that window, and, unlike Schedule 2, repeats are permitted where the prescriber has directed them, with the directed repeats suppliable after the first dispensing. Good practice keeps each supply to no more than 30 days' treatment, which most reputable TRT services follow, and which fits naturally over the monitoring cadence a well-run service already operates: prescription duration tracking review intervals is precisely what the high-risk framework expects.
Private prescriptions, which is what almost all TRT prescriptions are, work with none of the Schedule 2 and 3 machinery: no FP10PCD, no six-digit private controlled drug prescriber identifier, no monthly submission to the NHS Business Services Authority. Those requirements attach to Schedules 2 and 3 only. What remains is the ordinary law of private prescription-only medicine supply: a lawful prescription from a registered prescriber, the pharmacist satisfied of its genuineness, and the supply recorded in the pharmacy's prescription records and retained for two years. A pharmacy joining this vertical from an ADHD operation should actively unlearn the FP10PCD reflex; a pharmacy joining from general practice dispensing should actively learn the 28-day clock.
Emergency supply is the rule this vertical gets to use. Emergency supply at the request of a patient is unavailable for Schedule 1, 2 and 3 controlled drugs, the point our ADHD dispensing guide corrects at length, but it is available for Schedule 4, capped at five days' treatment, where the statutory conditions are met: the pharmacist has interviewed the patient, is satisfied of the immediate need and the impracticability of obtaining a prescription without undue delay, and the patient has been prescribed the medicine before. For a TRT patient between prescriptions, that is a genuine, lawful bridge, exercised on the pharmacist's professional judgement and recorded properly, and services should know it exists without treating it as a routine supply route, because a service leaning on emergency supply monthly has a prescription workflow problem, not an emergency.
How do possession, import and the illicit boundary actually work?
This is the section every TRT operator should be able to recite, because patients ask, websites mislead and the boundary is where the sector's social licence lives. Possession: uniquely among the drugs this site covers, the possession offence does not bite on Schedule 4 Part II substances where the drug is in the form of a medicinal product and is possessed for administration to oneself. That is why personal possession of steroids is not, in itself, prosecuted, and it is a Part II feature; it does not extend to the Part I benzodiazepine-type drugs, for which possession without a prescription remains unlawful. Supply:the exemption stops entirely at supply. Giving, selling or even sharing testosterone with another person is unauthorised Class C supply, up to fourteen years, and "supply" needs no money to change hands.
The personal-use latitude does not cover importation by post. An individual may import a Schedule 4 Part II medicinal product for self-administration only where they personally carry it; ordering testosterone from an overseas website for delivery by post or courier is an unlawful importation, whatever the seller's site says about legality, because import by that route needs a Home Office licence that private individuals do not hold. This is the single most common way otherwise law-abiding patients break the law in this category, and a legitimate service's patient communications should say so plainly.
Two practical corollaries for services. Patients travelling abroad with their medication should carry it in original packaging with evidence of the prescription, and for longer trips should check current Home Office guidance on personal import and export of controlled drugs, since licence requirements attach to larger quantities carried across borders; build that advice into the service rather than improvising it per patient. And the boundary with the illicit market is a clinical safety argument as much as a legal one: gym-sourced and web-imported product is of unverifiable identity, strength and sterility, and the legitimate pathway's entire pitch, made properly in the market analysis, is verified product, verified prescriber, monitored patient.
What does the pharmacy owe the operation?
The same professional spine as every vertical in this series, resized for Schedule 4. Verification: the prescriber checked against the General Medical Council register or their professional register, the standing forgery duty discharged before dispensing, and, for clinic relationships, standing verification maintained exactly as the CBPM workflow guide sets out, because the duty does not scale down with the Schedule. Records: private supplies in the prescription records for two years, batch details where the product is a compounded special, and, since most TRT products are licensed preparations, the specials regime with its five-year records applies only where a compounded formulation is genuinely supplied against special clinical need. Delivery: no statute prescribes the courier arrangements, but a controlled drug with a street value invites a diversion-aware standard as a matter of professional judgement: tracked, signature on delivery, and the proof filed with the dispensing record. Storage: no safe custody requirement, but responsible stock control and shrinkage awareness befitting a divertible drug. Advertising: testosterone is a prescription-only medicine, promotion to the public is prohibited, and product-led marketing is unlawful however it is styled, which is a website and social media discipline before it is anything else.
Structurally, all of this sits inside the clinic-plus-pharmacy architecture anatomised in the structural guide: the clinic owns the threshold philosophy and the monitoring, the pharmacy owns verification, supply and delivery, and the record that ties bloods to doses to supplies is the operation's real compliance asset, because in a vertical Schedule 4 has spared the register, the monitoring evidence is the compliance.
Key takeaways
- Testosterone is a Class C controlled drug in Schedule 4 Part II, alongside the other anabolic steroids, clenbuterol, the growth hormones and hCG, which many TRT services also prescribe.
- Schedule 4 Part II requires no CD register, no safe custody, no FP10PCD, no prescriber identifier and no NHSBSA submission; private supplies are recorded in the ordinary prescription records for two years.
- Prescriptions run 28 days from the appropriate date to first dispensing, repeats are permitted where directed, and 30 days' supply per dispensing remains good practice.
- Emergency supply exists in this vertical, capped at five days' treatment on the statutory conditions, a genuine contrast with the Schedule 2 categories.
- Personal possession of a medicinal product for self-administration is not an offence for Part II drugs, but supply to anyone else is Class C supply carrying up to fourteen years, and importation by post is unlawful even for personal use.
- The pharmacy's duties are verification, two-year supply records, specials records where compounded products are used, diversion-aware delivery and strict observance of the prohibition on promoting POMs to the public.
- With the register gone, the monitoring record is the compliance: bloods, doses and supplies on one auditable series is what a regulator, insurer or court will ask to see.
FAQs
Lighter law, same record.
The record Schedule 4 leaves as this vertical's compliance centre, bloods, dose decisions and supplies on one auditable series, is what Dataforge PMR holds: assessments embedded on the clinic's website, monitoring results tracked over time through custom fields, attributed prescriber notes, reminders driving the recall cadence, and dispensing with label printing on the same audit trail. Our publisher also writes the SOP suites and patient communications, including the import and travel guidance this article says every service should have. If you are building or tightening a TRT operation, book a 30-minute call.
Book a call